John Begley

Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance

Pharmacogenetics of Plasma Efavirenz Exposure after Treatment Discontinuation: An Adult AIDS Clinical Trials Group Study

Tenofovir Disoproxil Fumarate, Emtricitabine, and Efavirenz Versus Fixed-Dose Zidovudine/Lamivudine and Efavirenz in Antiretroviral-Naive Patients

Development of antibody-based assays for high throughput discovery and mechanistic study of antiviral agents against yellow fever virus

Clevudine for the treatment of chronic hepatitis B virus infection

Pharmacokinetics and Safety of Tenofovir in HIV-Infected Women During Labor and Their Infants During the First Week of Life

The search for nucleoside/nucleotide analog inhibitors of dengue virus

Emtricitabine

Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine

A computational approach for predicting off-target toxicity of antiviral ribonucleoside analogues to mitochondrial RNA polymerase

An RNA-centric dissection of host complexes controlling flavivirus infection

Ten years of dengue drug discovery: Progress and prospects

Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation

Antiretroviral Treatment of Adult HIV Infection

Prevention of Rectal SHIV Transmission in Macaques by Daily or Intermittent Prophylaxis with Emtricitabine and Tenofovir

Stem cell-derived polarized hepatocytes

Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial

Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)

EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design

Sexually Transmitted Diseases Treatment Guidelines, 2010

Concentrations of Tenofovir and Emtricitabine in Breast Milk of HIV-1-Infected Women in Abidjan, Cote d'Ivoire, in the ANRS 12109 TEmAA Study, Step 2

Experiences of modernity in the greenhouse: A cultural analysis of a physicist “trio” supporting the backlash against global warming

Pharmacokinetics and Safety of Tenofovir Alafenamide in HIV-Uninfected Subjects with Severe Renal Impairment

The Politicization of Climate Change and Polarization in the American Public's Views of Global Warming, 2001–2010

Penetration of Tenofovir and Emtricitabine in Mucosal Tissues: Implications for Prevention of HIV-1 Transmission

Emtricitabine Prodrugs with Improved Anti-HIV Activity and Cellular Uptake

Applications of Fluorine in Medicinal Chemistry

Pharmacokinetic and Pharmacodynamic Characteristics of Emtricitabine Support Its Once Daily Dosing for the Treatment of HIV Infection

Steady‐State Pharmacokinetics of Emtricitabine and Tenofovir Disoproxil Fumarate Administered Alone and in Combination in Healthy Volunteers

Book Review: Benedict XVI and the Search for Truth

Pharmacokinetic and Pharmacodynamic Characteristics of Emtricitabine Support Its Once Daily Dosing for the Treatment of HIV Infection

Pharmacokinetics of Tenofovir Disoproxil Fumarate and Ritonavir-Boosted Saquinavir Mesylate Administered Alone or in Combination at Steady State

Rapid Enantiomeric Quantification of an Antiviral Nucleoside Agent (d,l-FMAU, 2‘-Fluoro-5-methyl-β,d,l-arabinofurano- syluracil) by Mass Spectrometry